Our Mission

Transform the fields of gene editing, undiagnosed disease and oncology through discovery and detection of complex genetic changes.

KromaTiD’s patented dGH™ chromosome imaging platform enables detection of all types of chromosomal rearrangements including previously undetectable cryptic inversions.  Launched in 2013, KromaTiD’s research products and services are paving the way to a deeper understanding of genetic diseases, including cancers and developmental disorders.